Dysregulated CTSS expression or activity has been linked to several non-pulmonary diseases or outcomes of disease that are frequently observed as pulmonary comorbidities or additional symptoms such as cardiovascular disease and metabolic complications. The gene discussed is CTSS; the disease is cardiovascular disorder.